PRKN and neurodevelopmental disorder: However, PARK2 CNVs have also been found in control populations and an accurate analysis of the CNV location showed that, while CNVs targeting PARK2 exons 5–12 are significantly more frequent in neurodevelopmental disorders cases than in controls, CNVs involving exons 2–4 are well-tolerated and very common both in cases and controls48,49.